|Day Low/High||12.67 / 13.05|
|52 Wk Low/High||3.69 / 16.29|
Don't be in a rush. The key to accumulating stocks in this environment is to move incrementally.
If the Democrats sweep, you have perhaps the best single stock in the market.
I'm growing increasingly cautious but I'm still finding some stock picks that are working.
My focus remains on individual stock picking. The market timers are being crushed again.
The quick return to cannabis dispensaries shows that the demise of brick and mortar is a myth.
Still, Covid has forced attention on company balance sheets and a hard look at cash burn rates and investment choices.
These four names provide a way to stay in the game -- from a safe distance -- and grow some green.
Here is your "Marijuana Moment." Note that Illinois' Lieutenant Governor purchased the first recreational cannabis products on the first day of legalized sales for that state. Beneficiaries include , and .
Last week's "Trade of the Week" -- a basket of speculative cannabis stocks -- was intended, as I wrote, through the end of the year. In looking at the buy levels, it was a very successful idea -- with three of the stocks rising by more than 20% as ...
Cannabis stocks are continuing to get their groove back this morning - with good gains in , , , and .
While 2019 was a decidedly bad year for cannabis stocks, 2020 could be looking more positive.
Here is your Marijuana Moment. Last week, my Trade of the Week (and a half!) was a basket of cannabis stocks -- and I moved to large sized in all of them during the week (Note: The stocks started to roll higher on Friday): My package includes ($7.0...
As related to my year end cannabis play (and the possible "January Effect"), (+7%) and (+5%) are getting a bit jiggy after the long fall lower in 2019.
* My package includes ($7.00), ($5.69), ($5.45), ($2.25) and ($8.15) * It is likely that the maximum tax selling pressure is now virtually over * While technically "The Trade of the Week" - this is my favorite group to benefit from the "January Effe...
* In the hope for a "January Effect" after tax loss selling in December I added to ($7.82), ($6.70), ($5.90), ($5.29) and ($2.19) today.
* Let's get "Chai!" A pet peeve I have is that many talking heads don't update their investment ideas on an ongoing basis. I try to be transparent and honest about my winners and losers, and to further improve my own transparency/accountability I am...
I don't want there to be any ambiguity about the size of my positions or about my buy and short levels as I strive for as much transparency as possible. "When the time comes to buy, you won't want to." - Walter Deemer "When the time comes to sell, y...
I have established a small package of speculative cannabis stocks this morning which includes ($5.40), ($2.77), ($8.37) and ($5.30).
Though, in general, downside risk may dwarf upside reward, given the uncertainty of outcomes (for now) I really like the idea of having a long portfolio of stocks, with an intermediate term time frame, hedged with out of the money and puts ("I got g...
I'm considering establishing a long investment stake in a package of cannabis stocks, with emphasis on U.S.-based companies.
* CGC could trade up to over $30 on the successful House vote passage of the SAFE Banking Act announced last evening * While the short term may remain rocky (pot stocks are down by nearly 50% since April), investors with longer term timeframes shoul...
Pennsylvania just launched its medical marijuana program, and leading politicians have already started to discuss full legalization.
The start to 2019 looks to be much more promising for the cannabis industry than last year.
Gov. Andrew Cuomo's push to legalize adult use of marijuana would be welcome by these companies.
After Altria's investment in Cronos Group, which cannabis company will be the next target?
New Illinois legislation could signal a potential tidal wave of growth in the budding industry.
MPX is expanding its footprint in several U.S. states.
With tens of millions of dollars in funding, Chicago-based Green Thumb Industries has joined the ranks as one of the larger of publicly traded companies in the budding cannabis space.